Heptakis(2,6-O-dimethyl)β-cyclodextrin: A novel growth stimulant for Bordetella pertussis phase I

79Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The effect of cyclodextrins on the growth of Bordetella pertussis Tohama phase I in synthetic medium was evaluated. The addition of cyclodextrins, especially heptakis(2,6-O-dimethyl)β-cyclodextrin (MeβCD), to a complete synthetic medium such as Stainer-Scholte medium gave the same number of individual colonies and growth rates as those on Bordet-Gengou medium. Furthermore, with the addition of MeβCD, growth inhibition by fatty acids such as oleic or palmitic acid was overcome and normal cell growth was observed. This modified Stainer-Scholte medium, designated as cyclodextrin solid medium (CSM), supported excellent growth of 20 lyophilized clinical isolates. Serotypes of the organisms after 10 passages on this CSM plate were not changed. These results suggest that MeβCD is a significant growth stimulant and CSM is one of the most suitable synthetic media for culture of B. pertussis phase I.

Cite

CITATION STYLE

APA

Imaizumi, A., Suzuki, Y., Ono, S., Sato, H., & Sato, Y. (1983). Heptakis(2,6-O-dimethyl)β-cyclodextrin: A novel growth stimulant for Bordetella pertussis phase I. Journal of Clinical Microbiology, 17(5), 781–786. https://doi.org/10.1128/jcm.17.5.781-786.1983

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free